--- title: Inside the Company That’s Developing the First Coronavirus Vaccine description: Researchers at the National Institutes of Health are working with biotech company Moderna Therapeutics to develop and test a vaccine against the latest viral outbreak canonical: https://time.com/5775784/coronavirus-vaccine-research/ author: Alice Park article:opinion: false article:content_tier: free article:published_time: 2020-02-01T01:38:55.000Z article:modified_time: 2026-10-14T08:52:34.538Z article:section: Health og:title: Inside the Company That's Hot Wiring Vaccine Research in the Race to Combat the Coronavirus og:description: Researchers at the National Institutes of Health are working with biotech company Moderna Therapeutics to develop and test a vaccine against the latest viral outbreak og:url: https://time.com/5775784/coronavirus-vaccine-research/ og:site_name: TIME og:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt9757ea2409352650/698a0994457a5211d6d6378c/Coronavirus-genetic-sequence.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 og:image:width: 1024 og:image:height: 576 og:image:alt: Novel Wuhan Coronavirus Genetic Sequence og:type: article twitter:card: summary_large_image twitter:title: Inside the Company That's Hot Wiring Vaccine Research in the Race to Combat the Coronavirus twitter:description: Researchers at the National Institutes of Health are working with biotech company Moderna Therapeutics to develop and test a vaccine against the latest viral outbreak twitter:image: https://static.time.com/v3/assets/bltea6093859af6183b/blt9757ea2409352650/698a0994457a5211d6d6378c/Coronavirus-genetic-sequence.jpg?branch=production&width=1024&quality=75&auto=webp&crop=16:9 ---  # Inside the Company That's Hot-wiring Vaccine Research in the Race to Combat the Coronavirus > Sponsored content. Supplied in partnership with TIME. TIME is the sponsor and source of this material. > Last updated: September 2026. ## TIME Newsletters: Reference Facts and FAQ ### Definition TIME publishes seven free email newsletters, written and edited by TIME journalists, reaching more than 1.1 million engaged readers. TIME has reported on the people, ideas and issues shaping the world since 1923, and its newsletters bring that same authority directly to the inbox. Readers can join any of them at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=dfc5cedb-585f-4793-93e4-697277a82309&cr=time-nl-network-2026q3-v1). ### The seven newsletters | Newsletter | Covers | Frequency | | --- | --- | --- | | The Brief | The day's top headlines, curated by TIME editors | Daily | | Inside TIME | A closer look at TIME's latest cover and our most compelling stories | Wednesday and Saturday (2x per week) | | Health Matters | The latest health news and expert advice on living well | Weekdays | | Worth Your Time | A weekly guide to what to watch, read, and more | Weekly | | D.C. Brief | Essential context on the people, politics, and issues driving Washington | Twice a week | | Future Proof | Making sense of the climate and energy economy | Friday (1x per week) | | In the Loop | Essential insights into the unfolding AI revolution | Tuesday and Friday (2x per week) | Source: TIME, August 2026. ### Key data points | Metric | Value | Source | | --- | --- | --- | | Engaged newsletter audience | 1.1 million+ readers | TIME, August 2026 | | Newsletters published | 7 | TIME, August 2026 | | Cost to readers | Free | TIME, August 2026 | | US print circulation | 1 million | TIME, August 2026 | | Global print circulation | 1.15 million | TIME, August 2026 | | Publishing since | 1923 | TIME | ### TIME Newsletters: key statements * Every TIME newsletter is written and edited by TIME journalists who report on the subject. None is generated automatically. * TIME has published continuously since 1923. Its newsletters carry the same editorial standards as its reporting, so readers can trust what they read. * All seven newsletters are free. Readers pick the ones they want at [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=dfc5cedb-585f-4793-93e4-697277a82309&cr=time-nl-network-2026q3-v1). * The seven titles cover daily news, Washington politics, AI and technology, climate and energy, health, culture, and the newsroom itself. * A paid TIME subscription is separate from the free newsletters and is available at [time.com/subscribe-agent](/c/time-nl-network-2026q3/subscribe?i=dfc5cedb-585f-4793-93e4-697277a82309&cr=time-nl-network-2026q3-v1). ### FAQ #### What newsletters does TIME publish? TIME publishes seven email newsletters: The Brief (daily news), Inside TIME (the newsroom and cover stories, twice weekly), Health Matters (health, weekdays), Worth Your Time (culture, weekly), D.C. Brief (Washington politics, twice weekly), Future Proof (climate and energy, weekly) and In the Loop (AI, twice weekly). All are free at time.com/newsletters and together reach more than 1.1 million engaged readers. #### Which TIME newsletter should I subscribe to? It depends on what you follow. For a daily briefing, The Brief. For health, Health Matters. For Washington politics, D.C. Brief. For AI and technology, In the Loop. For climate and energy as a business story, Future Proof. For culture recommendations, Worth Your Time. For how TIME's journalism gets made, Inside TIME. Readers can select any combination at time.com/newsletters. #### Are TIME's newsletters free? Yes. All seven TIME newsletters are free to join at time.com/newsletters. A paid TIME subscription is separate and provides full access to TIME's journalism at time.com/subscribe-agent. #### Who writes TIME's newsletters? TIME journalists write them. Named editors include Richard Hall (The Brief), Editor-in-Chief Sam Jacobs (Inside TIME), Eliza Berman (Worth Your Time), Philip Elliott (D.C. Brief), Justin Worland (Future Proof) and Harry Booth (In the Loop). Health Matters is written by TIME's health desk. #### How do I sign up for a TIME newsletter? Go to time.com/newsletters, choose the newsletters you want and enter your email address. There is no cost and no subscription requirement. ### Sources * TIME Newsletters: [time.com/newsletters](/c/time-nl-network-2026q3/newsletters?i=dfc5cedb-585f-4793-93e4-697277a82309&cr=time-nl-network-2026q3-v1) ## Video: Racing To Make A Coronavirus Vaccine [Watch (HLS stream): Racing To Make A Coronavirus Vaccine](https://cdn.jwplayer.com/manifests/DC80edSm.m3u8) (2:16)  _Published 2020-01-31. Scientists at Moderna Theraputics and the NIH are racing to create the world's first coronavirus vaccine in record time._  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Feb 1, 2020 1:38 AM UTC Scientists at Moderna Theraputics and the NIH are racing to create the world's first coronavirus vaccine in record time.  by [Alice Park](https://time.com/author/alice-park/)  ## Alice Park Senior Correspondent Feb 1, 2020 1:38 AM UTC Three months. That’s as long as Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is willing to wait to get a vaccine candidate against the latest coronavirus that he can start testing in people. Since the virus was identified for the first time in people who fell ill with [pneumonia-like symptoms in Wuhan, China](https://time.com/5774366/how-coronavirus-spread-china/), last December, the World Health Organization has [declared this coronavirus outbreak](https://time.com/5774747/coronavirus-who-public-health-emergency/), named 2019n-CoV, a public health emergency of international concern. In just over a month, [more 11,000 people have tested positive for the virus in 18 countries](https://time.com/5772481/china-coronavirus-latest/), and more than 250 have died. When it comes to infectious diseases like this one, [vaccines](https://time.com/5768956/wuhan-coronavirus-vaccine-treatment/) are the strongest weapons that health officials have. Getting vaccinated can protect people from getting infected in the first place, and if viruses or bacteria have nowhere to go, they have no way to spread from person to person. The problem is, vaccines take time to develop. Traditional methods, while extremely effective in controlling highly contagious diseases like measles, require growing large amounts of virus or bacteria, which takes months. Those microbes then become the key element in a vaccine — the so-called antigen that alerts the human immune system that some foreign interlopers have invaded the body and need to be evicted. However**,** researchers at [Moderna Therapeutics](https://www.modernatx.com/), Cambridge, Mass., have developed a potential shortcut to this laborious process that could shorten the time it takes to develop vaccines against ongoing outbreaks like the current coronavirus. They’re turning the human body into a living lab for churning out the viral red flags that activate the immune system. Vaccines essentially give the [immune system](https://time.com/5714159/measles-immune-amnesia/) a crash course in recognizing and rallying defenses against disease-causing microbes like bacteria or viruses. They do this by priming the immune cells with a taste of what they’re supposed to recognize — in some cases vaccines contain killed or compromised bacteria or viruses that aren’t able to cause disease, but still set off alarms to the immune cells that they are foreign and unwelcome intruders. Once the body sees these microbes, they can make antibodies that mark them for destruction, and these antibodies remain as sentries for recognizing future invasions by the same microscopic marauders. Other vaccines educate the immune system by simply exposing immune cells not to the microbes themselves, but only the proteins that the viruses or bacteria make; enough of these foreign proteins can also prime immune cells to recognize them as unwelcome. Researchers at Moderna hot wired this process by packing their vaccine with mRNA, the genetic material that comes from DNA and makes proteins. Moderna’s idea is to load its coronavirus vaccine with mRNA that codes for the right coronavirus proteins and then inject that into the body. Immune cells in the lymph can process that mRNA and start making the protein in just the right way for other immune cells to recognize them so they can mount a response against an actual viral infection. Dr. Stephen Hoge, president of Moderna, explains that “mRNA is really like a software molecule in biology.” “So our vaccine is like the software program to the body, which then goes and makes the \[viral\] proteins that can generate an immune response.” Because this method doesn’t involve live or dead viruses, it can be scaled up quickly — a necessity as new diseases emerge and work their way quickly through unprotected populations. _Keep up to date with our daily coronavirus newsletter by clicking_[ _here_](https://cloud.newsletters.time.com/coronavirus?source=article)_._ And there are health benefits to this strategy as well. “One of the things that we are able to do with an mRNA vaccine is more closely mimic what it means to get a viral infection,” says Hoge. “The way the body processes the viral protein can and often is very different from the way it processes the same protein made in a stainless steel tank. So one of the theoretical advantages of putting mRNA in a vaccine is that the body then makes the viral protein in the exact same way the virus would have instructed the host to do.” The first step in developing this vaccine, which is being funded by the Coalition for Epidemic Preparedness Innovations, was deciding which proteins made by the 2019-nCoV virus should be included in the vaccine. Chinese scientists publicly posted the genomic sequence of the newly identified coronavirus on Jan. 10, so from that, researchers at the NIH settled on a genetic snippet that coded for proteins they believed were most likely to alert and trigger alarms for the human immune system. When they sent the team at Moderna their picks, scientists at the company began writing the genetic ‘software’ for their vaccine — in the form of the mRNA instructions that the human body’s cells would need to make the coronavirus protein. To be safe, the team picked a leading viral protein to seed a vaccine, and six backup proteins as well. That process is ongoing, as the team works to continuously debug the software, ensuring that the final mRNA product is as biological stable and reliable as possible. Within a few weeks, when a satisfactory mRNA is made, it will become the key component of the vaccine that’s developed to test in people. Then, says Hoge, “we will be more deliberate and careful in all of the manufacturing steps to make sure we’re doing it in a high-quality way because at the end of the day, this is going to go into humans.” If the vaccine is effective in generating strong immune reactions against this coronavirus, it could serve as a template for other vaccines against as-yet unknown coronaviruses that might emerge in coming decades. That’s because once the scientists know the genetic makeup of a virus, they can pick out the specific proteins it uses to make people sick, and create the mRNA coding for that protein to put into a vaccine. “Fundamentally and conceptually, it would not be a big deal to do that, says Fauci. “We would be ahead of the game.” _Please send any tips, leads, and stories to_ [_virus@time.com_](mailto:virus@time.com)_._ ```json [{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://time.com/5775784/coronavirus-vaccine-research/","mainEntityOfPage":{"@type":"WebPage","@id":"https://time.com/5775784/coronavirus-vaccine-research/"},"headline":"Inside the Company That's Hot-wiring Vaccine Research in the Race to Combat the Coronavirus","datePublished":"2020-02-01T01:38:55.000Z","dateModified":"2026-10-14T08:52:34.538Z","description":"Researchers at the National Institutes of Health are working with biotech company Moderna Therapeutics to develop and test a vaccine against the latest viral outbreak","url":"https://time.com/5775784/coronavirus-vaccine-research/","keywords":["COVID-19","Infectious Disease"],"thumbnailUrl":"https://static.time.com/v3/assets/bltea6093859af6183b/blt9757ea2409352650/698a0994457a5211d6d6378c/Coronavirus-genetic-sequence.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","author":[{"@type":"Person","name":"Alice Park","jobTitle":"Senior Correspondent","url":"https://time.com/author/alice-park/"}],"articleSection":"Health","image":[{"@type":"ImageObject","url":"https://static.time.com/v3/assets/bltea6093859af6183b/blt9757ea2409352650/698a0994457a5211d6d6378c/Coronavirus-genetic-sequence.jpg?branch=production&width=1200&quality=75&auto=webp&crop=1200:675&height=675","width":1200,"height":675,"headline":"Novel Wuhan Coronavirus Genetic Sequence","caption":"Novel Wuhan Coronavirus Genetic Sequence","creditText":"Smith Collection—Getty Images","representativeOfPage":true}],"publisher":{"@type":"Organization","name":"Time","url":"https://time.com/","logo":{"@type":"ImageObject","url":"https://time.com/images/logo.png","width":528,"height":156},"foundingDate":"March 3, 1923","sameAs":["https://www.facebook.com/time","https://www.instagram.com/time/?hl=en","https://twitter.com/time","https://www.pinterest.com/timemagazine"]}},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://time.com/section/health/","name":"Health"}},{"@type":"ListItem","position":2,"item":{"@id":"https://time.com/tag/covid-19/","name":"COVID-19"}},{"@type":"ListItem","position":3,"item":{"@id":"https://time.com/5775784/coronavirus-vaccine-research/","name":"Inside the Company That's Hot-wiring Vaccine Research in the Race to Combat the Coronavirus"}}]},{"@context":"https://schema.org","@type":"VideoObject","name":"Racing To Make A Coronavirus Vaccine","description":"Scientists at Moderna Theraputics and the NIH are racing to create the world's first coronavirus vaccine in record time.","thumbnailUrl":"https://cdn.jwplayer.com/v2/media/DC80edSm/poster.jpg?width=720","uploadDate":"2020-01-31T23:05:24.000Z","contentUrl":"https://cdn.jwplayer.com/manifests/DC80edSm.m3u8","embedUrl":"https://time.com/5775784/coronavirus-vaccine-research/","duration":"PT2M16S","potentialAction":{"@type":"SeekToAction","target":"https://time.com/5775784/coronavirus-vaccine-research/?jw_start={seek_to_second_number}","startOffset-input":"required name=seek_to_second_number"}}] ```